Home / Health / Pfizer Drug Restores Skin Color in Vitiligo Trials
Pfizer Drug Restores Skin Color in Vitiligo Trials
30 Jul
Summary
- Pfizer's oral drug shows success in restoring skin color.
- Two late-stage clinical trials demonstrated positive outcomes.
- Regulatory submissions are planned for vitiligo treatment approval.
Pfizer has announced promising results from two late-stage clinical trials concerning its oral medication for vitiligo. The drug has demonstrated the ability to restore skin color in patients affected by this common autoimmune skin disease.
These successful trials are a significant step forward, as Pfizer now plans to pursue regulatory submissions to gain approval for the treatment. The development offers potential new hope and therapeutic options for individuals living with vitiligo, an ongoing condition affecting skin pigmentation.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
